Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coagulation, fibrinolysis changes and DVT after major spinal surgery in Tibetan patients
ChiCTR2200063132Phase 4Not yet recruiting
- Sponsor
- Hospital of Chengdu Office of the People's Government of Tibet Autonomous Region
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in lumbar spinal stenosis (LSS), Herniated Lumbar Disk, thoracic spinal stenosis (TSS) and 2 more (3 arms), sponsored by Hospital of Chengdu Office of the People's Government of Tibet Autonomous Region. Primary endpoint: Lower extremity venous ultrasound. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
lumbar spinal stenosis (LSS)Herniated Lumbar Diskthoracic spinal stenosis (TSS)herniated thoracic disc (TDH)degenerative spinal conditions
Beyond the preview
Go deeper on ChiCTR2200063132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063132.